Irradiated fibroblasts protect burkitt lymphoma cells from apoptosis by a mechanism independent of BCL‐2
暂无分享,去创建一个
G. Bornkamm | L. Hültner | C. Gregory | A. Milner | M. Falk
[1] C. Gregory,et al. Prevention of programmed cell death in burkitt lymphoma cell lines by bcl‐2‐dependent and ‐independent mechanisms , 1992, International journal of cancer.
[2] J. Bonnefoy,et al. CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.
[3] G. Klein,et al. Expression of the epstein‐barr virus (EBV)‐encoded membrane protein LMP1 impairs the In vitro growth, clonability and tumorigenicity of an EBV‐negative burkitt lymphoma line , 1992, International journal of cancer.
[4] G. Lenoir,et al. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. , 1992, Blood.
[5] F. Behm,et al. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. , 1992, Blood.
[6] H. Stein,et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease , 1992, Cell.
[7] S. Markey,et al. The role of lactic acid in autocrine B-cell growth stimulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] E. Kieff,et al. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation , 1991, Journal of virology.
[9] I. Maclennan,et al. Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis , 1991, European journal of immunology.
[10] E. Kieff,et al. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.
[11] Gwyn T. Williams,et al. Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis , 1991, Nature.
[12] M. Rowe,et al. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. , 1990, The Journal of general virology.
[13] G. Lenoir,et al. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. , 1990, Blood.
[14] B. Chait,et al. Retinol is essential for growth of activated human B cells , 1990, The Journal of experimental medicine.
[15] D. Hilbert,et al. In vitro culture of a primary plasmacytoma that has retained its dependence on pristane conditioned microenvironment for growth. , 1990, Current topics in microbiology and immunology.
[16] I. Magrath. The pathogenesis of Burkitt's lymphoma. , 1990, Advances in cancer research.
[17] W. Hammerschmidt,et al. Genetic analysis of immortalizing functions of EpsteinBarr virus in human B lymphocytes , 1989, Nature.
[18] G. Guy,et al. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide “dual pathway” of signalling , 1988, European journal of immunology.
[19] J. Hatzfeld,et al. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. , 1988, Journal of immunology.
[20] L. Young,et al. Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.
[21] M. Lipinski,et al. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. , 1987, Journal of immunology.
[22] S. Swendeman,et al. The activation antigen BLAST‐2, when shed, is an autocrine BCGF for normal and transformed B cells. , 1987, The EMBO journal.
[23] C. Rooney,et al. Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines. , 1986, Journal of the National Cancer Institute.
[24] A. Wyllie,et al. Death and the cell. , 1986, Immunology today.
[25] G. Lenoir,et al. The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. , 1985, IARC scientific publications.
[26] J. Yates,et al. Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.
[27] I Lefkovits,et al. Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response. , 1984, Immunology today.
[28] G. Klein. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men , 1983, Cell.
[29] J. G. Hirsch,et al. THE EFFECTS OF MERCAPTOETHANOL AND OF PERITONEAL MACROPHAGES ON THE ANTIBODY-FORMING CAPACITY OF NONADHERENT MOUSE SPLEEN CELLS IN VITRO , 1972, The Journal of experimental medicine.
[30] J. P. JACOBS,et al. Characteristics of a Human Diploid Cell Designated MRC-5 , 1970, Nature.